Articles with public access mandates - Jeffrey ChamberlainLearn more
Not available anywhere: 8
Cardiac consequences to skeletal muscle-centric therapeutics for Duchenne muscular dystrophy
DW Townsend, S Yasuda, J Chamberlain, JM Metzger
Trends in Cardiovascular Medicine 19 (2), 49-54, 2009
Mandates: US National Institutes of Health
Therapy for neuromuscular disorders
ALH Arnett, JR Chamberlain, JS Chamberlain
Current opinion in genetics & development 19 (3), 290-297, 2009
Mandates: US National Institutes of Health
AAV6 vector production and purification for muscle gene therapy
CL Halbert, JM Allen, JS Chamberlain
Duchenne muscular dystrophy: methods and protocols, 257-266, 2018
Mandates: US National Institutes of Health
Preclinical studies for gene therapy of Duchenne muscular dystrophy
GL Odom, GB Banks, BR Schultz, P Gregorevic, JS Chamberlain
Journal of child neurology 25 (9), 1149-1157, 2010
Mandates: US National Institutes of Health
Muscling in: gene therapies for muscular dystrophy target RNA
JR Chamberlain, JS Chamberlain
Nature medicine 16 (2), 170-171, 2010
Mandates: US National Institutes of Health
Genetics and pathogenic mechanisms of cardiomyopathies in the Drosophila model
O Taghli-Lamallem, R Bodmer, JS Chamberlain, A Cammarato
Drug Discovery Today: Disease Models 5 (3), 125-134, 2008
Mandates: US National Institutes of Health
Muscular dystrophy: new opportunities for diagnosis and treatment
MA Babcock, FV Kostova, RT Moxley III, JS Chamberlain, BL Maria
Journal of child neurology 25 (9), 1080-1097, 2010
Mandates: US National Institutes of Health
Gene Replacement Therapy for Duchenne Muscular Dystrophy
K Hollinger, JM Crudele, JS Chamberlain
Muscle Gene Therapy, 327-337, 2019
Mandates: US National Institutes of Health
Available somewhere: 93
Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy
NE Bengtsson, JK Hall, GL Odom, MP Phelps, CR Andrus, RD Hawkins, ...
Nature communications 8 (1), 14454, 2017
Mandates: US National Institutes of Health
Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy
Y Lai, GD Thomas, Y Yue, HT Yang, D Li, C Long, L Judge, B Bostick, ...
The Journal of clinical investigation 119 (3), 624-635, 2009
Mandates: US National Institutes of Health
High levels of AAV vector integration into CRISPR-induced DNA breaks
KS Hanlon, BP Kleinstiver, SP Garcia, MP Zaborowski, A Volak, SE Spirig, ...
Nature communications 10 (1), 4439, 2019
Mandates: US National Institutes of Health
Sarcolemma-localized nNOS is required to maintain activity after mild exercise
YM Kobayashi, EP Rader, RW Crawford, NK Iyengar, DR Thedens, ...
Nature 456 (7221), 511-515, 2008
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Recombinant adeno-associated virus transduction and integration
BR Schultz, JS Chamberlain
Molecular Therapy 16 (7), 1189-1199, 2008
Mandates: US National Institutes of Health
Cas9 immunity creates challenges for CRISPR gene editing therapies
JM Crudele, JS Chamberlain
Nature communications 9 (1), 3497, 2018
Mandates: US National Institutes of Health
Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin
CE Winbanks, KL Weeks, RE Thomson, PV Sepulveda, C Beyer, H Qian, ...
The Journal of cell biology 197 (7), 997, 2012
Mandates: US National Institutes of Health
Progress toward gene therapy for Duchenne muscular dystrophy
JR Chamberlain, JS Chamberlain
Molecular Therapy 25 (5), 1125-1131, 2017
Mandates: US National Institutes of Health
An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells
A Filareto, S Parker, R Darabi, L Borges, M Iacovino, T Schaaf, ...
Nature communications 4 (1), 1549, 2013
Mandates: US National Institutes of Health
Therapeutic approaches to muscular dystrophy
A Goyenvalle, JT Seto, KE Davies, J Chamberlain
Human molecular genetics 20 (R1), R69-R78, 2011
Mandates: US National Institutes of Health
Prevention of muscle aging by myofiber-associated satellite cell transplantation
JK Hall, GB Banks, JS Chamberlain, BB Olwin
Science translational medicine 2 (57), 57ra83-57ra83, 2010
Mandates: US National Institutes of Health
Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice
GL Odom, P Gregorevic, JM Allen, E Finn, JS Chamberlain
Molecular Therapy 16 (9), 1539-1545, 2008
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program